Olfactory Training

Earn CME/CE in your profession:


Continuing Education Activity

Olfactory training is a non-pharmacological and non-surgical treatment option for patients with olfactory dysfunction. Patients undergoing olfactory training expose themselves to 4 different odors twice daily for at least 24 weeks. The main indications include post-infectious, post-traumatic, and idiopathic olfactory dysfunction and olfactory dysfunction due to Parkinson disease. This activity reviews the details of olfactory training and highlights the role of the interprofessional team during olfactory training.

Objectives:

  • Describe the physiology of olfactory training.
  • Identify the main indications for olfactory training.
  • Explain the protocol for olfactory training.
  • Summarize how an interprofessional team approach can provide patient benefit when performing olfactory training.

Introduction

About 20 percent of people in the general population have an impairment of the sense of smell.[1][2][3] Impaired olfaction leads to diminished quality of life. It can be dangerous, as environmental hazards such as the smell of natural gas or smoke may not be appreciated; the sense of taste is intimately connected with the sense of smell, and diminished taste can also result in missed indications of danger, such as spoiled or contaminated food.[4] Furthermore, impaired olfaction may be a warning sign for common neurodegenerative disorders, such as Alzheimer's dementia and Parkinson disease.[5][6] The most common causes of olfactory decline are sinonasal disease, viral infection, and nasofacial trauma.[7][8] 

If there is a clear structural pathology in the nose or brain, treatment may be oriented toward the underlying lesion, such as functional endoscopic nasal surgery for chronic rhinosinusitis with polyposis or neurosurgical interventions for an anterior skull base tumor.[3][8][9] In patients with damage to the olfactory epithelium and olfactory pathways due to inflammation, toxins, trauma, viral infection, or unknown causes, olfactory therapy may be appropriate.[3][8][9]

Medications such as corticosteroids for chronic rhinosinusitis and other inflammatory conditions may provide some relief from olfactory decline.[3][8] Other options include sodium citrate, zinc, and vitamins, but their efficacy has not been definitively proven to date.[3][8] A non-surgical and non-pharmacological approach to improve olfactory function is olfactory training, wherein patients expose themselves twice daily to different odors over the course of several months.[3][8] 

Several studies have described the efficacy of olfactory training.[10][11][12][13] In many cases, however, the studies' findings are questionable due to the absence of appropriate control groups or the lack of double-blinded experimental design.[3][13] Moreover, some patients with olfactory dysfunction recover spontaneously. Up to 20% of patients with post-traumatic olfactory dysfunction and up to 60% of patients with post-infectious olfactory dysfunction demonstrate spontaneous resolution of symptoms.[14][15] 

Additionally, younger patients, patients with relatively well-preserved olfactory function, females, and non-smokers have a good chance of a spontaneous improvement of olfactory functioning.[14] For patients who smoke, tobacco use should be discouraged because it is associated with diminished olfactory functioning, and continued use may thwart any attempt to improve the sense of smell.[2] 

Olfactory training is comparatively simple, and so far, serious side effects have not been reported. Although its precise mechanism of action and efficacy are incompletely understood, olfactory training is increasingly applied in routine care for patients with olfactory dysfunction of varying etiologies.[3][8][13]

Anatomy and Physiology

The olfactory system is the most primitive of the human special senses and is very closely connected to the limbic system, the seat of emotion.[16] Airborne particulates are inhaled into the nose and dissolved in the mucinous secretions of the nasal cavity; ciliary action brings them into contact with the olfactory epithelium, where water-soluble molecules from these particulates bind to chemoreceptors that subsequently transduce signals via the unmyelinated axons of the olfactory projections up through the cribriform plate of the ethmoid bone to the olfactory bulbs, and then ultimately to the olfactory cortex of the forebrain.[17]

The olfactory epithelium is located at the apex of the nasal cavity, along both the upper septum and the superior turbinate, as well as the roof of the nose. Olfaction has many roles, including recognition of danger and identification of edible food, and is responsible for a significant proportion of the human sense of taste; taste buds on the tongue can only differentiate among sweet, sour, salty, bitter, and umami (savory) flavors, but the human sense of smell can differentiate as many as 1 trillion odorants.[18] The chorda tympani branch of the facial nerve and the glossopharyngeal nerve provide the oral and pharyngeal portion of the taste pathway, but the major contribution of the sense of smell explains why olfactory decline tends to have a deleterious effect on gustation as well. Of note, the path of the olfactory nerve fibers through the skull base may represent a direct route by which infectious pathogens, such as SARS-CoV-2, may access the central nervous system.[19] The very thin fibers of the olfactory projections that travel through the perforations of the cribriform plate are also highly susceptible to shearing injury, which is why craniofacial trauma may result in hyposmia or anosmia.

Compared to other sensory systems, the olfactory system, including the olfactory epithelium and parts of the olfactory bulb, is unique in that it can adapt and regenerate.[20][21] Exposure to odors enhances this process and leads to improved olfactory functioning.[22][23] This regenerative phenomenon was first discovered in healthy human subjects in the mid-1990s.[24][25] A decade later, repeated exposure to odors was also shown to improve olfactory function for patients with deficiencies due to a broad range of etiologies.[26] Over the last ten years, numerous studies have confirmed the efficacy of olfactory training in humans.[10][11] Additionally, findings from several animal studies and functional imaging studies in humans confirm the effectiveness of olfactory training.[27][28][29][30]

Indications

Recent work suggests that olfactory training is more effective in younger individuals than in the elderly and is more effective in individuals with severe olfactory dysfunction than in individuals who are only mildly affected.[31] However, olfactory training may be employed to treat dysfunction from a broad range of etiologies, irrespective of age and baseline olfactory functioning.[8][11][13][10] The most common indications reported in the literature are:[10][11][12][8][31]

  • Post-infectious olfactory dysfunction: This is one of the most common causes of olfactory decline in clinical practice and one of the most common indications for olfactory training.[8][10][11] Following mild to severe upper respiratory tract infection, particularly virally-mediated, post-infectious olfactory dysfunction may occur. Olfactory testing in these patients shows diminished odor threshold and odor discrimination but normal odor identification.[32] Many patients with COVID-19 infection and decline of the chemical senses have this type of olfactory dysfunction.[33] The likelihood of improvement with olfactory training for patients with post-infectious olfactory dysfunction is comparatively good. A study involving more than 100 patients showed that 71% of patients with post-infectious olfactory dysfunction improved with olfactory training over one year, while 37% of patients without olfactory training spontaneously recovered over the same time period.[34] Neither abstinence from alcohol intake nor patient gender appears to affect the chance of improvement with olfactory training in patients with post-infectious olfactory dysfunction.[31] Olfactory training may be used in combination with corticosteroid treatment in selected patients with post-infectious olfactory dysfunction.[35][8][36] 
  • Post-traumatic olfactory dysfunction: This type of olfactory dysfunction may occur suddenly or with a delay after a brain or nasal injury.[8] Olfactory tests reveal diminished odor threshold and odor discrimination ability, while odor identification is normal.[32] Olfactory training has been reported to work for post-traumatic olfactory dysfunction, but results may be less dramatic than for post-infectious olfactory dysfunction.[37][38][39][26][31] Jiang et al. reported that 23% of patients with post-traumatic olfactory dysfunction had improvement of olfactory thresholds when training with phenyl ethyl alcohol, while 5% of patients improved when training with a mineral oil control.[37]
  • Parkinson disease: Patients with Parkinson disease have a severe impairment of olfactory functioning, which starts many years before the onset of motor symptoms such as tremor, rigidity, and bradykinesic gait.[40][41][42] Olfactory testing typically reveals impairment of odor discrimination and odor identification abilities, while the odor threshold is relatively normal.[32] Medication prescribed for Parkinson disease does not improve olfactory functioning, and in light of the progressive, neurodegenerative process that underlies Parkinson disease, olfactory training may be an important treatment option for patients who request rehabilitation of sense of smell.[43] The success rate with olfactory training in patients with Parkinson disease is lower than in patients with post-infectious olfactory dysfunction; about 20% of patients with Parkinson disease benefit from olfactory training, while 10% recover olfactory function spontaneously.[44]
  • Idiopathic olfactory dysfunction: This diagnosis is made after excluding all other causes of olfactory dysfunction.[8] These patients are less likely to experience a noticeable improvement in function after olfactory training than patients with post-infectious olfactory dysfunction.[31]

Contraindications

There are no described contraindications for olfactory training in terms of past medical or surgical history or medications. However, the value of olfactory training for treating olfactory dysfunction secondary to sinonasal disease remains yet to be determined.[8] 

Many patients with olfactory dysfunction due to sinonasal disease, especially those with chronic rhinosinusitis (with or without polyposis), may benefit from functional endoscopic surgery, generally with a pre-operative course of nasal topical steroids.[9] Thus, medical and surgical options may be considered first to manage patients with chronic rhinosinusitis.[8] Olfactory training may be considered for olfactory dysfunction secondary to sinonasal disease when surgical treatment options are exhausted, not possible, or after completion of surgical interventions.[9]

Equipment

The set-up for olfactory training includes four sniff bottles or jars (the volume of each container should be approximately 50 ml). Inside each container is 1 ml of an odor solution soaked into cotton pads. The different scents are typically phenylethyl alcohol (rose scent), eucalyptol (eucalyptus scent), citronella (lemon scent), and eugenol (clove scent­).[26] Olfactory treatment is an easy-to-use measure to improve olfactory dysfunction; it may be part of the therapeutic repertoire of both the specialized smell and taste clinic and the general ear, nose, and throat practice.[13]

Personnel

Patients need to be instructed on how to perform olfactory training by a physician, a nurse, a nurse practitioner, or other medical professionals with experience in managing olfactory dysfunction.

Preparation

The cause of the olfactory dysfunction needs to be determined using a comprehensive evaluation that follows consensus guidelines.[8] Additionally, patients must be counseled on the planned protocol for their olfactory training.

Technique

For standard olfactory training, the patients sniff twice daily (preferably once in the morning before breakfast and once in the evening before going to bed) for at least 20 to 30 seconds on each of the four scents separately. It is imperative that patients constantly sniff for 20 to 30 seconds on each odor without a break.   

The odors for training are presented in sniff bottles or jars. Typically, patients undergo olfactory training for at least 24 weeks. For patients with post-infectious olfactory dysfunction, olfactory training over the course of one year yielded better results than training for 16 weeks.[34] Another study showed that olfactory training with 12 odors was more effective than training with four odors in patients with post-infectious olfactory dysfunction.[45] A third study reported that high odor concentrations were more effective than low concentrations of odor for olfactory training in patients with post-infectious olfactory dysfunction.[46] These observations, however, have not been verified in patients with olfactory dysfunction due to other etiologies. For patients with hyposmia or anosmia without a history of sinonasal infection, olfactory training, following the standard protocol (that is, olfactory training with four different odors twice daily for at least 24 weeks), might be a good starting point.

Olfactory training over several months is challenging for both the patients and the health care provider. The effects may be less dramatic than expected, and it takes a high degree of discipline to follow the standard protocol of olfactory training.[3][13] An olfactory training ball can be used to improve adherence and outcomes of olfactory training. The olfactory training ball is roughly the size of a baseball, has four tubes containing the different odors, and is lightweight and ergonomic.[47] Another approach to improving olfactory training adherence and outcomes is to call or schedule patients for regular office visits (e.g., every six weeks) to monitor their compliance and progress.

Complications

Olfactory training has been assessed in more than 40 clinical studies, and results have been reviewed in several independent meta-analyses.[10][11][12][36] None of the studies found complications arising from olfactory training. However, patients may find olfactory testing tiresome because of the daily nature of the training over several months.

Clinical Significance

Except for post-viral olfactory dysfunction and olfactory dysfunction secondary to chronic rhinosinusitis, there is no established medical or surgical treatment for olfactory dysfunction.[8] Thus, olfactory training is the only treatment option available to patients with olfactory dysfunction due to other etiologies. For this reason, olfactory training is particularly important for the management of patients with olfactory decline.

Enhancing Healthcare Team Outcomes

A multi-professional team is critical for achieving the best possible results of olfactory training. This team should include several members such as medical clerks, nurses, nurse practitioners, and physicians. Medical clerks are responsible for the coordination of patients' appointments and ordering and storing the materials needed for olfactory training. Nurses and nurse practitioners screen patients to determine candidacy for olfactory training. They also instruct patients to ensure the olfactory training protocol is followed correctly and thus facilitate the best possible outcome of the therapy—furthermore, they follow up with patients to ensure adherence to the protocol.

Physicians oversee and supervise medical clerks, nurses, and nurse practitioners. Additionally, regular conferences ensure that all team members are apprised of the patients' progress undergoing olfactory training, ensuring all patients' needs are addressed and problems resolved. It is also critical for the team to educate itself regarding current developments in the field of olfaction and olfactory training.


Article Details

Article Author

Martin Kronenbuerger

Article Editor:

Manfred Pilgramm

Updated:

1/3/2022 1:44:37 PM

PubMed Link:

Olfactory Training

References

[1]

Murphy C,Schubert CR,Cruickshanks KJ,Klein BE,Klein R,Nondahl DM, Prevalence of olfactory impairment in older adults. JAMA. 2002 Nov 13;     [PubMed PMID: 12425708]

[2]

Vennemann MM,Hummel T,Berger K, The association between smoking and smell and taste impairment in the general population. Journal of neurology. 2008 Aug;     [PubMed PMID: 18677645]

[3]

Doty RL, Treatments for smell and taste disorders: A critical review. Handbook of clinical neurology. 2019;     [PubMed PMID: 31604562]

[4]

Croy I,Nordin S,Hummel T, Olfactory disorders and quality of life--an updated review. Chemical senses. 2014 Mar;     [PubMed PMID: 24429163]

[5]

Marin C,Vilas D,Langdon C,Alobid I,López-Chacón M,Haehner A,Hummel T,Mullol J, Olfactory Dysfunction in Neurodegenerative Diseases. Current allergy and asthma reports. 2018 Jun 15;     [PubMed PMID: 29904888]

[6]

Doty RL, Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? The Lancet. Neurology. 2017 Jun;     [PubMed PMID: 28504111]

[7]

Hüttenbrink KB,Hummel T,Berg D,Gasser T,Hähner A, Olfactory dysfunction: common in later life and early warning of neurodegenerative disease. Deutsches Arzteblatt international. 2013 Jan;     [PubMed PMID: 23450985]

[8]

Hummel T,Whitcroft KL,Andrews P,Altundag A,Cinghi C,Costanzo RM,Damm M,Frasnelli J,Gudziol H,Gupta N,Haehner A,Holbrook E,Hong SC,Hornung D,Hüttenbrink KB,Kamel R,Kobayashi M,Konstantinidis I,Landis BN,Leopold DA,Macchi A,Miwa T,Moesges R,Mullol J,Mueller CA,Ottaviano G,Passali GC,Philpott C,Pinto JM,Ramakrishnan VJ,Rombaux P,Roth Y,Schlosser RA,Shu B,Soler G,Stjärne P,Stuck BA,Vodicka J,Welge-Luessen A, Position paper on olfactory dysfunction. Rhinology. 2016 Jan 31;     [PubMed PMID: 28623665]

[9]

Fokkens WJ,Lund VJ,Mullol J,Bachert C,Alobid I,Baroody F,Cohen N,Cervin A,Douglas R,Gevaert P,Georgalas C,Goossens H,Harvey R,Hellings P,Hopkins C,Jones N,Joos G,Kalogjera L,Kern B,Kowalski M,Price D,Riechelmann H,Schlosser R,Senior B,Thomas M,Toskala E,Voegels R,Wang de Y,Wormald PJ, European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology. Supplement. 2012 Mar;     [PubMed PMID: 22764607]

[10]

Pekala K,Chandra RK,Turner JH, Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis. International forum of allergy     [PubMed PMID: 26624966]

[11]

Sorokowska A,Drechsler E,Karwowski M,Hummel T, Effects of olfactory training: a meta-analysis. Rhinology. 2017 Mar 1;     [PubMed PMID: 28040824]

[12]

Kattar N,Do TM,Unis GD,Migneron MR,Thomas AJ,McCoul ED, Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2020 Jul 14;     [PubMed PMID: 32660334]

[13]

Turner JH, Olfactory training: what is the evidence? International forum of allergy     [PubMed PMID: 32776673]

[14]

Hähner A,Hummel T,Stuck BA, [Olfactory disorders and their therapy]. HNO. 2014 Dec;     [PubMed PMID: 25270839]

[15]

Kuo CL,Shu CH, Risk of decline and chance of improvement in olfaction among patients with post-traumatic olfactory loss. The Journal of laryngology and otology. 2015 Dec;     [PubMed PMID: 26490496]

[16]

Albrecht J,Wiesmann M, [The human olfactory system. Anatomy and physiology]. Der Nervenarzt. 2006 Aug     [PubMed PMID: 16871378]

[17]

Eslinger PJ,Damasio AR,Van Hoesen GW, Olfactory dysfunction in man: anatomical and behavioral aspects. Brain and cognition. 1982 Jul     [PubMed PMID: 6765474]

[18]

Bushdid C,Magnasco MO,Vosshall LB,Keller A, Humans can discriminate more than 1 trillion olfactory stimuli. Science (New York, N.Y.). 2014 Mar 21     [PubMed PMID: 24653035]

[19]

Fodoulian L,Tuberosa J,Rossier D,Boillat M,Kan C,Pauli V,Egervari K,Lobrinus JA,Landis BN,Carleton A,Rodriguez I, SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain. iScience. 2020 Dec 18     [PubMed PMID: 33251489]

[20]

Wilson DA,Best AR,Sullivan RM, Plasticity in the olfactory system: lessons for the neurobiology of memory. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry. 2004 Dec;     [PubMed PMID: 15534037]

[21]

Schwob JE,Youngentob SL,Ring G,Iwema CL,Mezza RC, Reinnervation of the rat olfactory bulb after methyl bromide-induced lesion: timing and extent of reinnervation. The Journal of comparative neurology. 1999 Sep 27;     [PubMed PMID: 10441232]

[22]

Youngentob SL,Kent PF, Enhancement of odorant-induced mucosal activity patterns in rats trained on an odorant identification task. Brain research. 1995 Jan 23;     [PubMed PMID: 7719728]

[23]

Hudson R,Distel H, Induced peripheral sensitivity in the developing vertebrate olfactory system. Annals of the New York Academy of Sciences. 1998 Nov 30;     [PubMed PMID: 9929591]

[24]

Cain WS,Stevens JC,Nickou CM,Giles A,Johnston I,Garcia-Medina MR, Life-span development of odor identification, learning, and olfactory sensitivity. Perception. 1995;     [PubMed PMID: 8734544]

[25]

Livermore A,Laing DG, Influence of training and experience on the perception of multicomponent odor mixtures. Journal of experimental psychology. Human perception and performance. 1996 Apr;     [PubMed PMID: 8934843]

[26]

Hummel T,Rissom K,Reden J,Hähner A,Weidenbecher M,Hüttenbrink KB, Effects of olfactory training in patients with olfactory loss. The Laryngoscope. 2009 Mar;     [PubMed PMID: 19235739]

[27]

Kim BY,Park J,Kim E,Kim B, Olfactory Ensheathing Cells Mediate Neuroplastic Mechanisms After Olfactory Training in Mouse Model. American journal of rhinology     [PubMed PMID: 31680531]

[28]

Marin C,Laxe S,Langdon C,Alobid I,Berenguer J,Fuentes M,Bernabeu M,Mullol J, Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons. Molecular neurobiology. 2019 Dec;     [PubMed PMID: 31177483]

[29]

Negoias S,Pietsch K,Hummel T, Changes in olfactory bulb volume following lateralized olfactory training. Brain imaging and behavior. 2017 Aug;     [PubMed PMID: 27448159]

[30]

Kollndorfer K,Fischmeister FP,Kowalczyk K,Hoche E,Mueller CA,Trattnig S,Schöpf V, Olfactory training induces changes in regional functional connectivity in patients with long-term smell loss. NeuroImage. Clinical. 2015;     [PubMed PMID: 26594622]

[31]

Liu DT,Pellegrino R,Sabha M,Altundag A,Damm M,Poletti SC,Croy I,Hähner A,Oleszkiewicz A,Mandy C,Hummel T, Factors associated with relevant olfactory recovery after olfactory training: a retrospective study including 601 participants. Rhinology. 2020 Sep 9;     [PubMed PMID: 32901616]

[32]

Whitcroft KL,Cuevas M,Haehner A,Hummel T, Patterns of olfactory impairment reflect underlying disease etiology. The Laryngoscope. 2017 Feb;     [PubMed PMID: 27556251]

[33]

Whitcroft KL,Hummel T, Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020 Jun 23;     [PubMed PMID: 32432682]

[34]

Konstantinidis I,Tsakiropoulou E,Constantinidis J, Long term effects of olfactory training in patients with post-infectious olfactory loss. Rhinology. 2016 Jun;     [PubMed PMID: 27017331]

[35]

Fleiner F,Lau L,Göktas Ö, Active olfactory training for the treatment of smelling disorders. Ear, nose,     [PubMed PMID: 22614554]

[36]

Hura N,Xie DX,Choby GW,Schlosser RJ,Orlov CP,Seal SM,Rowan NR, Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. International forum of allergy     [PubMed PMID: 32567798]

[37]

Jiang RS,Twu CW,Liang KL, The effect of olfactory training on odor identification in patients with traumatic anosmia. International forum of allergy     [PubMed PMID: 31433573]

[38]

Pellegrino R,Han P,Reither N,Hummel T, Effectiveness of olfactory training on different severities of posttraumatic loss of smell. The Laryngoscope. 2019 Aug;     [PubMed PMID: 30848489]

[39]

Bratt M,Moen KG,Nordgård S,Helvik AS,Skandsen T, Treatment of posttraumatic olfactory dysfunction with corticosteroids and olfactory training. Acta oto-laryngologica. 2020 Sep;     [PubMed PMID: 32491937]

[40]

Haehner A,Hummel T,Reichmann H, A clinical approach towards smell loss in Parkinson's disease. Journal of Parkinson's disease. 2014;     [PubMed PMID: 24322062]

[41]

Sommer U,Hummel T,Cormann K,Mueller A,Frasnelli J,Kropp J,Reichmann H, Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Movement disorders : official journal of the Movement Disorder Society. 2004 Oct;     [PubMed PMID: 15390014]

[42]

Haehner A,Hummel T,Hummel C,Sommer U,Junghanns S,Reichmann H, Olfactory loss may be a first sign of idiopathic Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2007 Apr 30;     [PubMed PMID: 17357143]

[43]

Haehner A,Hummel T,Wolz M,Klingelhöfer L,Fauser M,Storch A,Reichmann H, Effects of rasagiline on olfactory function in patients with Parkinson’s disease. Movement disorders : official journal of the Movement Disorder Society. 2013 Dec;     [PubMed PMID: 24190245]

[44]

Haehner A,Tosch C,Wolz M,Klingelhoefer L,Fauser M,Storch A,Reichmann H,Hummel T, Olfactory training in patients with Parkinson's disease. PloS one. 2013;     [PubMed PMID: 23613901]

[45]

Altundag A,Cayonu M,Kayabasoglu G,Salihoglu M,Tekeli H,Saglam O,Hummel T, Modified olfactory training in patients with postinfectious olfactory loss. The Laryngoscope. 2015 Aug;     [PubMed PMID: 26031472]

[46]

Damm M,Pikart LK,Reimann H,Burkert S,Göktas Ö,Haxel B,Frey S,Charalampakis I,Beule A,Renner B,Hummel T,Hüttenbrink KB, Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. The Laryngoscope. 2014 Apr;     [PubMed PMID: 23929687]

[47]

Saatci O,Altundag A,Duz OA,Hummel T, Olfactory training ball improves adherence and olfactory outcomes in post-infectious olfactory dysfunction. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2020 Jul;     [PubMed PMID: 32246254]